Portion of New Duke Medicine Circle Opens Dec. 5 (http://construction.dukemedicine.org/)
Dec. 1, 2011
As part of preparations for the opening of the new Duke Cancer Center in February, a portion of the new Duke Medicine Circle will open to vehicular traffic on Dec. 5.
Costly Blood Clots More Common than Expected Among Cancer Patients (DukeHealth.org)
Sept. 19, 2011
An analysis of more than 30,000 cancer patients has shown that blood clots are a more common complication than doctors may realize, causing additional hospitalizations and driving up the cost of care, according to a study led by a Duke Cancer Institute researcher.
Duke Team Finds New Clues to How Cancer Spreads (DukeHealth.org)
June 27, 2011
Cancer cells circulating in the blood carry newly identified proteins that could be screened to improve prognostic tests and suggest targets for therapies, report scientists at the Duke Cancer Institute.
Blocking the Critical Structure that Lets Cancer Cells Move -- Their Feet (DukeHealth.org)
Dec. 16, 2010
Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way -- by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because blocking these "feet" also blocks proteins in the feet that burn through intact tissue and let cancer cells enter new cells.
Scientists Decode Secrets of a Very Common Virus that Can Cause Cancer (DukeHealth.org)
Dec. 16, 2010
About 90 percent of people are infected at some time in their lives with Epstein-Barr virus (EBV), usually with no ill effects. But individuals with compromised immune systems, such as people with organ transplants or HIV infection, have a greater risk of cancer occurring because of this virus.
National Cancer Institute Renews Duke Comprehensive Cancer Center Core Grant (DukeHealth.org)
Sept. 14, 2010
The Duke Comprehensive Cancer Center (DCCC) has received a 5-year, $30 million core grant renewal from the National Cancer Institute (NCI) to support its broad range of clinical, research, and educational programs designed to lessen the impact of cancer upon the lives of people throughout North Carolina and beyond.